Neoadjuvant chemotherapy for high-risk intrahepatic cholangiocarcinoma – does pathologic response mean better outcomes?
Reed I. Ayabe, Natalia Paez-Arango, Jeannelyn S. Estrella, Timothy E. Newhook, Ching‐Wei D. Tzeng, Yun Shin Chun, Sunyoung Lee, Milind Javle, Jean‐Nicolas Vauthey, Hop S. Tran Cao
Topics & Concepts
MedicineGemcitabineInternal medicineIntrahepatic CholangiocarcinomaChemotherapyCisplatinRegimenStage (stratigraphy)CohortOncologyComplete responseNeoadjuvant therapyGastroenterologyHepatectomySurgeryCancerResectionBreast cancerPaleontologyBiologyCholangiocarcinoma and Gallbladder Cancer StudiesGallbladder and Bile Duct DisordersHepatocellular Carcinoma Treatment and Prognosis